Sign in
Facet browsing currently unavailable
Page 5 of 3821 results
Sort by: relevance publication year
|
Annotated Patent Selections JOURNAL ARTICLE published January 2001 in Expert Opinion on Therapeutic Patents |
|
The isolation, culture and therapeutic application of pluripotent stem cells derived from human embryos JOURNAL ARTICLE published September 2002 in Expert Opinion on Therapeutic Patents |
|
JOURNAL ISSUE published August 1996 in Expert Opinion on Therapeutic Patents |
|
Erratum JOURNAL ARTICLE published August 2008 in Expert Opinion on Therapeutic Patents |
|
5-Amino-2-carbonylthiophene derivatives for use as p38 MAPK inhibitors in the treatment of inflammatory diseases JOURNAL ARTICLE published October 2005 in Expert Opinion on Therapeutic Patents |
|
HIV protease inhibitors based on amino acid derivatives JOURNAL ARTICLE published April 2003 in Expert Opinion on Therapeutic Patents |
|
Novel substituted 2,3-benzodiazepin-4-ones as non-competitive AMPA antagonists and positive modulators JOURNAL ARTICLE published July 1998 in Expert Opinion on Therapeutic Patents |
|
Clinical potential of the HA-1 peptide, a minor histocompatibility antigen JOURNAL ARTICLE published October 1999 in Expert Opinion on Therapeutic Patents |
|
JOURNAL ISSUE published July 2005 in Expert Opinion on Therapeutic Patents |
|
JOURNAL ISSUE published December 2000 in Expert Opinion on Therapeutic Patents |
|
JOURNAL ISSUE published January 2005 in Expert Opinion on Therapeutic Patents |
|
Phosphodiesterase 4 inhibitors JOURNAL ARTICLE published November 1997 in Expert Opinion on Therapeutic Patents |
|
Protease-activated drug delivery JOURNAL ARTICLE published 2003 in Expert Opinion on Therapeutic Patents |
|
Small molecule IL-4 antagonists JOURNAL ARTICLE published July 2002 in Expert Opinion on Therapeutic Patents |
|
Merck & Co.: updated analysis of patenting with comparative data for thirty-five companies JOURNAL ARTICLE published August 1997 in Expert Opinion on Therapeutic Patents |
|
Patent Evaluation Central & Peripheral Nervous Systems: Neuronal sodium/calcium channel blockers as therapeutics for stroke and epilepsy JOURNAL ARTICLE published September 1996 in Expert Opinion on Therapeutic Patents |
|
Evaluation of WO2012037132 – a novel scaffold for selective JAK1 inhibition JOURNAL ARTICLE published September 2012 in Expert Opinion on Therapeutic Patents |
|
Further improvements in the technology of HSV-1-based amplicon vectors JOURNAL ARTICLE published July 2008 in Expert Opinion on Therapeutic Patents |
|
Vascular endothelial growth factor tyrosine kinase inhibitors JOURNAL ARTICLE published June 2004 in Expert Opinion on Therapeutic Patents |
|
JOURNAL ISSUE published May 2001 in Expert Opinion on Therapeutic Patents |